RK

Rajagopal Kanagam

Active Director Director DIN 09183423
DIN 09183423 First appointment May 2021 Primary industry Education & Learing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Rajagopal Kanagam

Data last updated:

Rajagopal Kanagam is a Director at Cellzyme Biotech India Private Limited (since 2021). The company operates in Education & Learing. Cellzyme Biotech India Private Limited reported revenue of ₹25 Lakh (FY 2020).

DIN 09183423
Primary Designation Director
Industry Education & Learing
First Appointment 24 May 2021
Oldest Company Age 13 yrs
Largest company Cellzyme Biotech India Private Limited · ₹25 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 May 20212013₹25 Lakh (FY 2020)Active

Board colleagues of Rajagopal Kanagam

NameDINCompanyDesignation
Rajagopal Naveen Kumar06514072Cellzyme Biotech India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cellzyme Biotech India Private Limited
Premium access

Shareholding and investment profile for Rajagopal Kanagam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajagopal Kanagam

Rajagopal Kanagam currently holds 1 directorship: Cellzyme Biotech India Private Limited (Director, since 24 May 2021, revenue ₹25 Lakh (FY 2020)).

Rajagopal Kanagam was first appointed on 24 May 2021 as Director at Cellzyme Biotech India Private Limited.

The current boards of Rajagopal Kanagam's companies include Rajagopal Naveen Kumar (Cellzyme Biotech India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available